PET imaging for differentiating recurrent brain tumor from radiation necrosis
- 1 January 2005
- journal article
- review article
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 43 (1) , 35-47
- https://doi.org/10.1016/j.rcl.2004.09.009
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Cerebral Radiation NecrosisThe Neurologist, 2003
- Positron emission tomography with injection of methionine as a prognostic factor in gliomaJournal of Neurosurgery, 2001
- Enantioselective synthesis of 2‐[18F]fluoro‐L‐tyrosine by catalytic phase‐transfer alkylationJournal of Labelled Compounds and Radiopharmaceuticals, 2001
- 18-fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant gliomaCancer, 1997
- Effects of radiotherapy on the cellular uptake of carbon-14 labeledl-methionine in tumor tissueNuclear Medicine and Biology, 1995
- Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.American Journal of Roentgenology, 1994
- The accumulation of11C-methionine in cerebral glioma patients studied with PETActa Neurochirurgica, 1990
- Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studiesAmerican Journal of Roentgenology, 1988
- Positron Emission Tomography Using [18F] Fluorodeoxyglucose in Brain Tumors A Powerful Diagnostic and Prognostic ToolInvestigative Radiology, 1987
- Prediction of survival in glioma patients by means of positron emission tomographyJournal of Neurosurgery, 1985